Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis

Objectives: To investigate the predictive ability of radiomics signature to predict the prognosis of early-stage primary lung adenocarcinoma (≤3 cm) with no lymph node metastasis (pathological stage I). Materials and Methods: This study included consecutive patients with lung adenocarcinoma (≤3 cm)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Lv, Lv, Li, Lin, Wang, Yan-Mei, Zhao, Shuang, Miao, Lei, Gao, Yan-Ning, Li, Meng, Wu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406362/
https://www.ncbi.nlm.nih.gov/pubmed/36010257
http://dx.doi.org/10.3390/diagnostics12081907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406362/
https://www.ncbi.nlm.nih.gov/pubmed/36010257
http://dx.doi.org/10.3390/diagnostics12081907

Ejemplares similares